• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠纹状体中多巴胺D-1和D-2受体的不同靶点大小

Distinct target size of dopamine D-1 and D-2 receptors in rat striatum.

作者信息

Nielsen M, Klimek V, Hyttel J

出版信息

Life Sci. 1984 Jul 16;35(3):325-32. doi: 10.1016/0024-3205(84)90116-4.

DOI:10.1016/0024-3205(84)90116-4
PMID:6235424
Abstract

Frozen rat striatal tissue was exposed to 10 MeV electrons from a linear accelerator. Based on the theory of target size analysis, the molecular weights of dopamine D-1 receptors (labelled by 3H-piflutixol) and dopamine D-2 receptors (labelled by 3H-spiroperidol) were 79,500 daltons and 136,700 daltons, respectively. The size of the dopamine-stimulated adenylate cyclase was 202,000 daltons. The estimated molecular sizes were deduced by reference to proteins with known molecular weights which were irradiated in parallel. The results showed that the molecular entities for 3H-piflutixol binding and 3H-spiroperidol binding were not identical. The present results do not allow conclusions as to whether D-1 and D-2 receptors are two distinct proteins in the membrane, or whether the receptors are located on the same protein. In the latter case the binding of 3H-spiroperidol needs the presence of a second molecule.

摘要

将冷冻的大鼠纹状体组织暴露于来自直线加速器的10兆电子伏特电子束下。根据靶标大小分析理论,多巴胺D-1受体(用³H-匹莫齐特标记)和多巴胺D-2受体(用³H-螺哌啶醇标记)的分子量分别为79,500道尔顿和136,700道尔顿。多巴胺刺激的腺苷酸环化酶的大小为202,000道尔顿。通过参考平行照射的已知分子量蛋白质来推断估计的分子大小。结果表明,³H-匹莫齐特结合和³H-螺哌啶醇结合的分子实体并不相同。目前的结果无法得出关于D-1和D-2受体是膜中两种不同的蛋白质,还是受体位于同一蛋白质上的结论。在后一种情况下,³H-螺哌啶醇的结合需要第二种分子的存在。

相似文献

1
Distinct target size of dopamine D-1 and D-2 receptors in rat striatum.大鼠纹状体中多巴胺D-1和D-2受体的不同靶点大小
Life Sci. 1984 Jul 16;35(3):325-32. doi: 10.1016/0024-3205(84)90116-4.
2
Loss of rat striatal dopamine receptors with ageing is selective for D-2 but not D-1 sites: association with increased non-specific binding of the D-1 ligand [3H]piflutixol.随着年龄增长,大鼠纹状体多巴胺受体的丧失对D-2位点具有选择性,而对D-1位点则不然:与D-1配体[3H]匹氟噻醇非特异性结合增加有关。
Eur J Pharmacol. 1984 Oct 1;105(1-2):171-4. doi: 10.1016/0014-2999(84)90663-0.
3
Irradiation inactivation studies of the dopamine D1 receptor and dopamine-stimulated adenylate cyclase in rat striatum.大鼠纹状体中多巴胺D1受体和多巴胺刺激的腺苷酸环化酶的辐射失活研究。
Neurosci Lett. 1987 Dec 16;83(1-2):167-72. doi: 10.1016/0304-3940(87)90235-7.
4
The relationship between the occupation of the D-1 dopamine receptor by [3H]piflutixol and the activity of dopamine-sensitive adenylate cyclase in rat striatal membranes.大鼠纹状体膜中[3H]匹莫齐特对D-1多巴胺受体的占据与多巴胺敏感腺苷酸环化酶活性之间的关系。
Biochem Pharmacol. 1991 Jul 5;42(2):229-37. doi: 10.1016/0006-2952(91)90708-d.
5
Target size of dopamine D-1 receptors in rat corpus striatum estimated by binding of the benzazepine 3H-SCH 23390.
Pharmacol Toxicol. 1987 Apr;60(4):255-7. doi: 10.1111/j.1600-0773.1987.tb01747.x.
6
Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.R-SK与F 38393对纹状体D1和D2多巴胺受体的[3H]匹莫齐特结合而非[3H]螺哌隆结合的选择性和立体特异性相互作用:与SCH 23390的比较。
Eur J Pharmacol. 1984 Mar 2;98(3-4):433-6. doi: 10.1016/0014-2999(84)90294-2.
7
Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.急性利血平治疗可诱导大鼠纹状体中与D-1多巴胺受体相关的腺苷酸环化酶活性下调。
Biochem Pharmacol. 1992 Jul 7;44(1):83-91. doi: 10.1016/0006-2952(92)90041-g.
8
Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake.在摄入顺式氟哌噻吨18个月后停药,纹状体多巴胺刺激的腺苷酸环化酶活性持续增加超过6个月,但在1年后消失。
Biochem Pharmacol. 1983 Sep 1;32(17):2495-9. doi: 10.1016/0006-2952(83)90008-4.
9
Specific [3H]piflutixol binding to CHAPS-solubilised rat striatal preparations involves dopamine D-2 but not D-1 binding sites.特异性[3H]匹氟噻吨与CHAPS增溶的大鼠纹状体制剂的结合涉及多巴胺D-2而非D-1结合位点。
J Neurochem. 1986 Feb;46(2):413-21. doi: 10.1111/j.1471-4159.1986.tb12984.x.
10
Differential affinity of dopaminergic agonists and antagonists for D1 and D2 dopamine receptors in rat striatum.多巴胺能激动剂和拮抗剂对大鼠纹状体中D1和D2多巴胺受体的不同亲和力。
Pharmacol Res Commun. 1983 Jul;15(7):697-706. doi: 10.1016/s0031-6989(83)80041-1.

引用本文的文献

1
The regulation of AMPA receptor-binding sites.AMPA受体结合位点的调控。
Mol Neurobiol. 1998 Winter;17(1-3):33-58. doi: 10.1007/BF02802023.
2
Characterization of binding of 3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions.3H-SCH 23390与多巴胺D-1受体结合的特性。与其他D-1和D-2测量指标的相关性以及选择性损伤的影响。
J Neural Transm. 1987;68(3-4):171-89. doi: 10.1007/BF02098496.
3
Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
作用于中枢多巴胺受体和胆碱能受体的药物对阿扑吗啡、溴隐亭或毒扁豆碱诱导的大鼠打哈欠反应的相互作用。
Br J Pharmacol. 1989 Apr;96(4):843-8. doi: 10.1111/j.1476-5381.1989.tb11893.x.
4
Bromocriptine induces climbing behaviour: possible D-1 or D-2 dopamine receptor involvement.溴隐亭诱导攀爬行为:可能涉及D-1或D-2多巴胺受体。
Psychopharmacology (Berl). 1990;100(2):275-80. doi: 10.1007/BF02244418.